Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects

This study has been completed.
Sponsor:
Collaborator:
University of Florida
Information provided by (Responsible Party):
Glycadia
ClinicalTrials.gov Identifier:
NCT00544921
First received: October 15, 2007
Last updated: February 9, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)